vorasidenib
servier
['vorasidenib', 'indigo']
 new #asco23 study summary for patients: #targetedtherapy vorasidenib delays disease progression for grade 2 #glioma with an idh mutation #btsm #indigostudy
Timely, trusted, compassionate doctor-approved info from @ASCO. Signup https://t.co/2KibiNRMFU

We can't answer individual medical questions.

Retweet ≠Endorsement